Pharma Companies Invest In US While India Still Depends On China For APIs
Published on: May 10, 2026, 6:23 p.m. | Source: Deccan Chronicle
“For decades, India built its reputation as the “pharmacy of the world” by manufacturing low-cost generic medicines that reached millions across Africa, Latin America, and Asia. But now, the industry appears determined to move beyond the image of being merely a low-cost generic supplier,” said Ravi Uday Bhaskar, former Director General of Pharmexcil
